相关实验视频
Updated: Jul 1, 2025

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.5K
塔拉克斯醇通过抑制COX-2/PGE2/JAK2/STAT3/MMP通路增强了膀癌细胞的辐射敏感性
Quanxin Wang1, Ruiqi Zhang1, Yijun He1
1Department of Radiobiology, Institute of Radiation Medicine, Fudan University, Shanghai, China.
International journal of radiation biology
|March 5, 2024
概括
塔拉克斯醇通过向COX-2来增强膀癌的辐射敏感性,减少癌细胞迁移和入侵. 这种天然化合物通过克服放射电阻,有望改善放射治疗结果.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 癌症生物学 癌症生物学
背景情况:
- 膀癌 (BCa) 的放射治疗是有效的,但受到获得的放射电阻 (ARR) 的限制.
- 循环氧基因酶-2 (COX-2) 在癌症中经常过度表达,并与放射电阻有关.
研究的目的:
- 为了研究塔拉醇 (Tara) 作为BCa的放射敏感剂.
- 探索塔拉的作用机制,重点关注其对COX-2的影响.
主要方法:
- 进行了细胞活力 (MTT试验),放射性敏感性 (克隆原试验),迁移和入侵试验.
- 使用siRNA降低了COX-2表达;通过球体形成评估了茎状性质.
- 在体内研究中,Tara和/或辐射 (IR) 治疗的小鼠进行了瘤异种移植.
主要成果:
- 塔拉治疗和COX-2倒置显著增强了BCa细胞的辐射敏感性.
- 塔拉降低了癌细胞迁移,入侵和干细胞状性质,与减少的JAK2,p-STAT3,MMP2和MMP9表达相关.
- 在缺乏COX-2的细胞中,Tara的辐射敏感作用减弱,证实COX-2是点.
结论:
- 塔拉克斯醇通过向COX-2通路,作为膀癌的放射敏感剂.
- 该机制涉及对STAT3酸化和MMP2/MMP9.9表达的调节.
- 塔拉具有改善膀癌放射治疗结果的潜力.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K

